Schedule 13D
This Amendment No. 6 (“Amendment”) amends and supplements the Schedule 13D filed with the SEC on October 31, 2014, as previously amended by the Schedule 13D/A filed with the SEC on September 2, 2015, as previously amended by the Schedule 13D/A filed with the SEC on March 21, 2016, as previously amended by the Schedule 13D/A filed with the SEC on June 8, 2016, as previously amended by the Schedule 13D/A filed with the SEC on January 12, 2018, and as previously amended by the Schedule 13D/A filed with the SEC on May 4, 2020 (the “Schedule 13D”). Except as set forth in this Amendment, the Schedule 13D remains unchanged. Unless otherwise indicated, all capitalized terms used herein but not defined herein shall have the same meaning as set forth in the Schedule 13D.
The following items of this Schedule 13D are hereby amended as follows.
ITEM 4. PURPOSE OF TRANSACTION
The Filers hereby add the following disclosure to this Item 4:
From March 19, 2021 to March 23, 2021, the Filers sold an aggregate of 636,261 shares of Common Stock in open market transactions on the NASDAQ Global Select Market for aggregate gross proceeds of $5,474,639.
On March 19, 2021, the Filers filed a Form 144 with the SEC disclosing their intent to sell up to 1,000,000 shares of Common Stock. Subject to applicable securities laws and regulations, market conditions and other factors, the Filers plan to sell such shares of Common Stock opportunistically, but reserve the right to acquire securities of the Issuer, including shares of Common Stock. There can be no assurance, however, that the Filers will take any such action.
The Filers do not have any present plan or proposal that would relate to or result in any of the matters set forth in subparagraphs (a) – (j) of Item 4 of Schedule 13D, except as set forth herein or such as would occur upon completion of any of the actions discussed herein.
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER
(a) and (b) The beneficial ownership of the Common Stock by each Filer at the date hereof is reflected on that Filer’s cover page.
(c) The Filers sold the following shares of Common Stock in the open market in the sixty days preceding the date of this filing:
| | | | | | | | | | | | | | |
Name | | Purchase or Sale | | Date | | | Number of Shares | | | Weighted Average Price per Share | |
K&M Douglas Trust | | Sale | | | 3/19/21 | | | | 109,760 | | | $ | 8.84 | |
James Douglas and Jean Douglas Irrevocable Descendants’ Trust | | Sale | | | 3/19/21 | | | | 90,552 | | | $ | 8.84 | |
Douglas Family Trust | | Sale | | | 3/19/21 | | | | 46,648 | | | $ | 8.84 | |
James E. Douglas III | | Sale | | | 3/19/21 | | | | 27,440 | | | $ | 8.84 | |
K&M Douglas Trust | | Sale | | | 3/22/21 | | | | 83,138 | | | $ | 8.73 | |